Scholarlink

<p>White spot syndrome, caused by the white spot syndrome virus (WSSV), is a devastating viral disease responsible for significant economic losses in the shrimp farming industry. In the search for natural therapeutic alternatives against WSSV, this study explored the antiviral potential of portoamides, natural peptides produced by the cyanobacterium <i>Phormidium</i> sp. LEGE 05292. Given that the structural proteins of the viral envelope, specifically VP28, VP26, and VP24, are the primary mediators of host cell attachment, they serve as promising targets for antiviral drug development. Our approach combined <i>in vivo</i> post-infection histopathological analysis with <i>in silico</i> molecular docking to assess the antiviral efficacy of portoamides. In the <i>in vivo</i> study, crabs were injected with portoamides alongside WSSV and monitored for 30 days post-infection. The antiviral activity of portoamides was evaluated through survival rates and histopathological observations. The results revealed that crabs treated with portoamides showed improved survival and reduced signs of viral infection compared to the control group. In parallel, <i>in silico</i> molecular docking analysis was conducted to assess the binding affinity between portoamides and the viral envelope proteins VP28, VP26, and VP24. The docking results demonstrated that these proteins exhibited the highest binding energies with portoamides, indicating a strong interaction that could potentially inhibit viral attachment and replication. Our findings suggest that portoamides effectively inhibit WSSV replication by interacting with the viral envelope proteins, thereby preventing the virus from establishing infection in crabs. Moreover, it is hypothesized that portoamides may stimulate the immune system in crabs, further enhancing resistance to WSSV infection. However, additional studies are needed to fully understand the immunomodulatory mechanisms involved. These preliminary results highlight the potential of portoamides as natural antiviral agents for combating WSSV in aquaculture settings, paving the way for future research on their application in disease management strategies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

In vivo and in silico preliminary evaluation of the cyanobacterial peptides portoamides A and B against the white spot syndrome virus in freshwater crabs (Paratelphusa hydrodomous)

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年4月5日

查看全文
  • Bharath Raja,
  • Vidya Radhakrishnan,
  • Sudhakaran Raja,
  • Sandra Pereira,
  • Catarina Gonçalves,
  • Vitor Vasconcelos,
  • Mariana Reis,
  • Joana R. Almeida

摘要

White spot syndrome, caused by the white spot syndrome virus (WSSV), is a devastating viral disease responsible for significant economic losses in the shrimp farming industry. In the search for natural therapeutic alternatives against WSSV, this study explored the antiviral potential of portoamides, natural peptides produced by the cyanobacterium Phormidium sp. LEGE 05292. Given that the structural proteins of the viral envelope, specifically VP28, VP26, and VP24, are the primary mediators of host cell attachment, they serve as promising targets for antiviral drug development. Our approach combined in vivo post-infection histopathological analysis with in silico molecular docking to assess the antiviral efficacy of portoamides. In the in vivo study, crabs were injected with portoamides alongside WSSV and monitored for 30 days post-infection. The antiviral activity of portoamides was evaluated through survival rates and histopathological observations. The results revealed that crabs treated with portoamides showed improved survival and reduced signs of viral infection compared to the control group. In parallel, in silico molecular docking analysis was conducted to assess the binding affinity between portoamides and the viral envelope proteins VP28, VP26, and VP24. The docking results demonstrated that these proteins exhibited the highest binding energies with portoamides, indicating a strong interaction that could potentially inhibit viral attachment and replication. Our findings suggest that portoamides effectively inhibit WSSV replication by interacting with the viral envelope proteins, thereby preventing the virus from establishing infection in crabs. Moreover, it is hypothesized that portoamides may stimulate the immune system in crabs, further enhancing resistance to WSSV infection. However, additional studies are needed to fully understand the immunomodulatory mechanisms involved. These preliminary results highlight the potential of portoamides as natural antiviral agents for combating WSSV in aquaculture settings, paving the way for future research on their application in disease management strategies.